UroGen Pharma Ltd Stock Analysis
Technical stock analysis for Tue 15'th Jan 2019
UroGen Pharma Ltd gained 0.72% in the last trading day, rising from $50.05 to $50.41 The price has risen in 7 of the last 10 days and is up by 17.07% over the past 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 37 843 more shares were traded than the day before. In total, 93 599 shares bought and sold for approximately $4.72 million.
Close price at the end of the last trading day (Tuesday, 15th Jan 2019) of the URGN stock was $50.41. This is 0.72% more than the trading day before Monday, 14th Jan 2019.
During day the stock fluctuated 4.52% from a day low at $49.31 to a day high of $51.54.
30 day high of the URGN stock price was $55.49 and low was $40.61.
90 day high was $55.49 and low was $36.95.
52 week high for the UroGen Pharma Ltd - $69.57 and low - $36.95.
UroGen Pharma Ltd lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 14.56% during the next 3 months and, with 90% probability hold a price between $50.41 and $63.28 at the end of this period.
Only positive signals in the chart today. UroGen Pharma Ltd holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $51.27. On a fall, the stock will find some support from the long-term average at approximately $47.18. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. A buy signal was issued from a pivot bottom point on Thursday January 10, 2019, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.
Relative Strength Index (RSI)
RSI14 is 69 and the stock is currently not being overbought or oversold
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $47.57 and $47.00.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, UroGen Pharma Ltd finds support just below today's level at $47.57. If this is broken, then the next support from accumulated volume will be at $47.00 and $42.52.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $2.23 between high and low, or 4.52%. For the last week, the stock has had a daily average volatility of 4.76%.
Our recommended stoploss: $47.25 (-6.26%) (This stock has high daily movements and this gives high risk. There is a buy signal from pivot bottom found 3 days ago.)
Very Low Low Medium High Very High
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term.
|URGN $50.41 $0.36(0.72%)|
URGN is up $0.36 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for URGN based on the 1-3 month system that more than doubles the S&P 500.
Click here – the URGN analysis is free »